|
Prior to his appointment in 1999 as Chairman and CEO of Mongram Biosciences (formerly ViroLogic) a biotechnology company focused on developing treatments for viral, immunologic, and oncologic diseases. Dr. Young served in a number of positions at Genentech from 1980 to 1999, most recently as Chief Operating Officer, where he was responsible for all development, operations, and commercial activities. Previous to that, he held various positions at Eli Lilly and Company for 14 years. He serves on the boards of Biogen/Idec and Human Genome Sciences. Dr. Young is an elected member of the National Academy of Engineering (1993) in recognition of his contributions to the development of manufacturing technologies for biotechnology-based pharmaceutical products, and he was awarded an Honorary Doctorate of Engineering degree from Purdue University (2001). He received a BS in Chemical Engineering from Purdue University and an MBA from Indiana University. | 